Niu, Jiaxin
Banner MD Anderson Cancer Center
2 papers on CoChatORCID 0000-0001-9018-287X
Most cited papers
- Verified
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
Kakadia, S., Yarlagadda, N., Awad, R., Kundranda, M., Niu, J., Naraev, B., Mina, L., Dragovich, T., Gimbel, M., & Mahmoud, F. (2018) · OncoTargets and Therapy
Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers
Cited by 277
- Verified
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., et al. (2021) · npj Precision Oncology
Neuroendocrine Tumor Research AdvancesMonoclonal and Polyclonal Antibodies Research
Cited by 80
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free